Aspira Pathlab & Diagnostics Ltd Sees Notable Gains Amid Market Volatility
Aspira Pathlab & Diagnostics Ltd is experiencing notable buying activity, achieving gains for two consecutive days despite a challenging month. Year-to-date, the stock has outperformed the Sensex, showing significant resilience over the past year. Its current trading position reflects a mix of stability and complex market sentiment.
Aspira Pathlab & Diagnostics Ltd is currently witnessing significant buying activity, with the stock gaining 1.99% today, contrasting sharply with the Sensex's decline of 0.34%. This marks the second consecutive day of gains for Aspira, accumulating a total return of 4.03% over this period. Despite a challenging month where the stock has decreased by 16.93%, its year-to-date performance remains positive at 8.57%, significantly outperforming the Sensex, which is down 3.14% for the same timeframe. Over the past year, Aspira has shown remarkable resilience, with a 91.46% increase compared to the Sensex's modest 3.59% rise.
The stock opened at 64.6 and has maintained this price level throughout the trading session, indicating stability amid the buying pressure. Aspira's current trading position is above its 100-day and 200-day moving averages, yet it remains below its 5-day, 20-day, and 50-day moving averages. This performance suggests a complex market sentiment, potentially driven by sector-specific developments or company-related news, contributing to the heightened buying interest.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
